Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 421-430 of 9364

Page
per page
  1. iMDK
    B5809 iMDK
    Summary: PI3K and endogenous midkine (MDK) expression inhibitor
      ≥4.23 mg/mL
  2. L-AP4
    B6202 L-AP4
    Summary: group III metabotropic glutamate receptor agonist
      Soluble in H2O or NaOH
  3. Dihydrokainic acid
    B6208 Dihydrokainic acid
    Summary: EAAT2(GLT1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake
      <5.38 mg/mL
  4. L-Quisqualic acid
    B6221 L-Quisqualic acid
    Summary: AMPA receptors and metabotropic glutamate receptors agonist
      Soluble in H2O or NaOH
  5. Kainic acid
    B6226 Kainic acid
    Summary: Selective kainate receptor agonist; for epilepsy and neurodegenerative disease models
      ≥11.05 mg/mL
  6. (S)-AMPA
    B6238 (S)-AMPA
    Summary: AMPA agonist
      <18.62 mg/mL
  7. (RS)-3,5-DHPG
    B6268 (RS)-3,5-DHPG
    Summary: group I metabotropic glutamate receptor agonist
      insoluble in H2O
  8. NBQX disodium salt
    B6566 NBQX disodium salt
    Summary: An AMPA/kainate glutamate receptor antagonist
      ≥53 mg/mL
  9. (RS)-AMPA hydrobromide
    B6585 (RS)-AMPA hydrobromide
    Summary: AMPAR agonist
      Soluble to 10 mM in water with gentle warming
  10. STO-609 acetate
    B6787 STO-609 acetate
    Target: CaM-KK
    Summary: Ca2+-calmodulin-dependent protein kinase kinase inhibitor
      Soluble in DMSO

Items 421-430 of 9364

Page
per page